Leafline Labs, LLC — Form D/A
Leafline Labs, LLC of Cottage Grove, MN, a company, filed a Form D amendment with the SEC on 2015-10-30. The offering totals $15.1M, of which $14.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-10-30
- Form: D/A
- Accession: 0001209191-15-077384
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.1M
- Amount sold: $14.9M
- Remaining: $176K
- Investors: 141
- Date of first sale: 2014-12-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-229430
Issuer
- Name: Leafline Labs, LLC
- CIK: 0001621013
- Entity type: Limited Liability Company
- Jurisdiction: MINNESOTA
- Incorporated: 2014
- Address: 8235 97th Street South, Cottage Grove, MN, 55016
- Phone: 844-532-3546
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Paul Bachman | Director | Cottage Grove, MN |
| Peter Bachman | Director | Cottage Grove, MN |
| Peter Bachman | Executive Officer | Cottage Grove, MN |
| Emmanuel Munson-Regala | Executive Officer | Cottage Grove, MN |
| Mitchell Baruchowitz | Director | Lakewood, CO |
| Mitchell Baruchowitz | Promoter | Lakewood, CO |
| Colin Kelley | Executive Officer | Woodbury, MN |
| Ethan Ruby | Director | San Francisco, CA |
| Ethan Ruby | Promoter | San Francisco, CA |
| Gary Starr | Promoter | Cincinnati, OH |
| Tara Mulloy | Executive Officer | Baltimore, MD |
| Mark Bachman | Promoter | Newport Beach, CA |
| Peter Bachman | Promoter | Cottage Grove, MN |
| Paul Bachman | Promoter | Cottage Grove, MN |
| Kelly Henry | Promoter | Cottage Grove, MN |
| Glenn Taylor | Director | Cottage Grove, MN |
| Glenn Taylor | Promoter | Cottage Grove, MN |
| Andrew Bachman | Director | Cottage Grove, MN |
| Andrew Bachman | Executive Officer | Cottage Grove, MN |
| Andrew Bachman | Promoter | Cottage Grove, MN |
| Christopher Weidling | Executive Officer | Minneapolis, MN |
| Christopher Weidling | Promoter | Minneapolis, MN |
Other filings by this issuer (2)
More